Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Tejeda HA, Shippenberg TS, Henriksson R.

Cell Mol Life Sci. 2012 Mar;69(6):857-96. doi: 10.1007/s00018-011-0844-x. Epub 2011 Oct 16. Review.

PMID:
22002579
2.

Dynorphin/KOP and nociceptin/NOP gene expression and epigenetic changes by cocaine in rat striatum and nucleus accumbens.

Caputi FF, Di Benedetto M, Carretta D, Bastias del Carmen Candia S, D'Addario C, Cavina C, Candeletti S, Romualdi P.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Mar 3;49:36-46. doi: 10.1016/j.pnpbp.2013.10.016. Epub 2013 Nov 1.

PMID:
24184686
3.

κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction.

Butelman ER, Yuferov V, Kreek MJ.

Trends Neurosci. 2012 Oct;35(10):587-96. doi: 10.1016/j.tins.2012.05.005. Epub 2012 Jun 16. Review.

4.

Content of dynorphins and kappa-opioid receptors in distinct brain regions of C57BL/6 and DBA/2 mice.

Jamensky NT, Gianoulakis C.

Alcohol Clin Exp Res. 1997 Nov;21(8):1455-64.

PMID:
9394118
5.

The dynorphin/kappa opioid receptor system: a new target for the treatment of addiction and affective disorders?

Shippenberg TS.

Neuropsychopharmacology. 2009 Jan;34(1):247. doi: 10.1038/npp.2008.165. Review. No abstract available.

6.

Acute intermittent morphine increases preprodynorphin and kappa opioid receptor mRNA levels in the rat brain.

Wang XM, Zhou Y, Spangler R, Ho A, Han JS, Kreek MJ.

Brain Res Mol Brain Res. 1999 Mar 20;66(1-2):184-7.

PMID:
10095091
7.

Involvement of kappa/dynorphin system in WIN 55,212-2 self-administration in mice.

Mendizábal V, Zimmer A, Maldonado R.

Neuropsychopharmacology. 2006 Sep;31(9):1957-66. Epub 2005 Nov 16.

8.

The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.

Wee S, Koob GF.

Psychopharmacology (Berl). 2010 Jun;210(2):121-35. doi: 10.1007/s00213-010-1825-8. Epub 2010 Mar 30. Review.

9.
10.

The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.

Bruchas MR, Land BB, Chavkin C.

Brain Res. 2010 Feb 16;1314:44-55. doi: 10.1016/j.brainres.2009.08.062. Epub 2009 Aug 28. Review.

11.

Kappa Opioids, Salvinorin A and Major Depressive Disorder.

Taylor GT, Manzella F.

Curr Neuropharmacol. 2016;14(2):165-76. Review.

12.

Kinase cascades and ligand-directed signaling at the kappa opioid receptor.

Bruchas MR, Chavkin C.

Psychopharmacology (Berl). 2010 Jun;210(2):137-47. doi: 10.1007/s00213-010-1806-y. Epub 2010 Apr 17. Review.

13.

Role of serotonin in the regulation of the dynorphinergic system by a kappa-opioid agonist and cocaine treatment in rat CNS.

D'Addario C, Di Benedetto M, Izenwasser S, Candeletti S, Romualdi P.

Neuroscience. 2007 Jan 5;144(1):157-64. Epub 2006 Oct 19.

PMID:
17055175
14.
16.

Acute amphetamine exposure selectively desensitizes kappa-opioid receptors in the nucleus accumbens.

Xia YF, He L, Whistler JL, Hjelmstad GO.

Neuropsychopharmacology. 2008 Mar;33(4):892-900. Epub 2007 Jun 6.

17.

The role of the dynorphin/κ opioid receptor system in anxiety.

Hang A, Wang YJ, He L, Liu JG.

Acta Pharmacol Sin. 2015 Jul;36(7):783-90. doi: 10.1038/aps.2015.32. Epub 2015 May 18. Review.

18.
19.
20.

Dynorphins in regulation of immune system functions.

Gein SV.

Biochemistry (Mosc). 2014 May;79(5):397-405. doi: 10.1134/S0006297914050034. Review.

PMID:
24954590

Supplemental Content

Support Center